Background
Chemical and lifescience companies are increasingly spinning-off their infrastructure to focus on their core activities.
The general trend from conglomerates with many sub-critical businesses to focused companies with globally leading businesses is continuing.
FESTEL CAPITAL carried out an interview-based market study to get a clear picture of the current situation and a profound knowledge of future trends and key success factors.
|